AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

HealthBeacon SHA

Declaration of Voting Results & Voting Rights Announcements Jun 2, 2022

Preview not available for this file type.

Download Source File

author: Cathal Barry
date: 2022-06-02 13:15:00+00:00


2 June 2022

About HealthBeacon

Ends

HealthBeacon plc

Results of Annual General Meeting

Each of the resolutions proposed at the Company’s Annual General Meeting, held on 2 June 2022, was passed by way of poll. The table below sets out the results of the poll on each resolution as set out in the 2022 Notice of Annual General Meeting, which is available on the Company’s website www.healthbeacon.com

For further information, contact:

Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company that develops products for managing injectable medications for patients in the home. The HealthBeacon Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence (AI) driven data analytics. The Company operates across Europe, North America and the United Kingdom and employs more than 70 people and has obtained more than 30 design and utility patents. Peer reviewed evidence supports a 19% improvement in therapy persistence by patients and up to 26% improvement in adherence to therapy, which improves clinical outcomes and significantly improves efficiency in health systems. The Company’s mission is to become the world’s leading digital therapeutics platform for injectable medications.

Resolution Total Votes For % Against % Withheld
01 Approval of financial statements and reports 9,584,386 9,584,386 100.00% - 0.00% -
02 Approval of remuneration report 9,568,224 9,445,114 98.71% 123,110 1.29% -
03A Re-elect Robert Garber 9,568,224 9,559,021 99.90% 9,203 0.10% -
03B Re-elect Jim Joyce 9,568,224 9,568,224 100.00% - 0.00% -
03C Re-elect Laurence Flavin 9,568,224 9,568,224 100.00% - 0.00% -
03D Re-elect Mary Harney 9,584,386 9,584,386 100.00% - 0.00% -
03E Re-elect Rebecca Shanahan 9,568,224 9,568,224 100.00% - 0.00% -
03F Re-elect Orla O’Gorman 9,568,224 9,568,224 100.00% - 0.00% -
04 Remuneration of auditors 9,568,224 9,568,224 100.00% - 0.00% -
05 Authority to allot shares 9,568,224 9,568,224 100.00% - 0.00% -
06 Adoption of LTIP 9,568,224 9,445,114 98.71% 123,110 1.29% -
07 Disapplication of pre-emption up to 5% 9,568,224 9,568,224 100.00% - 0.00% -
08 Disapplication of pre-emption up to an additional 5% 9,568,224 9,568,224 100.00% - 0.00% -
09 Authority to purchase the Company’s ordinary shares 9,568,224 9,568,224 100.00% - 0.00% -
10 Authority to re-issue treasury shares 9,568,224 9,568,224 100.00% - 0.00% -

| Enquiries:
| |
| --- | --- |
| HealthBeacon:
Laurence Flavin
| [email protected] |
| Goodbody (Euronext Listing Sponsor and Broker):
David Kearney | +353 (1) 667 0420 |
| Stephen Kane | |
|
Drury (Public Relations): | |
| Billy Murphy | +353 (0) 87 231 3085 |
| Cathal Barry | +353 (0) 87 227 9281 |

Talk to a Data Expert

Have a question? We'll get back to you promptly.